EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Association of plasma endocan levels with metabolic parameters and predictive value of endocan for the development of complications in patients with type 2 diabetes mellitus: An observational study

Kenana Ljuca, Mensura Aščerić, Olivera Batić-Mujanović, Svjetlana Loga-Zec, Nadina Ljuca, Emir Bećirović, Samir Bejić, Predrag Jovanović, Minela Bećirović

Biomolecules and Biomedicine · 2024

DOI: 10.17305/bb.2024.11512 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Biomolecules and Biomedicine, 2024. Verfasst von Kenana Ljuca und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, University Clinical Center Ljubljana, Ljubljana, Slovenia; Health Center of Sarajevo Canton, Sarajevo, Bosni…. Hauptthemen laut MEDLINE: Proteoglycans, Diabetes Mellitus, Type 2, Neoplasm Proteins. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of the current research was to investigate the association between plasma endocan levels and metabolic control parameters, as well as to evaluate its predictive value for clinical complications in patients with type 2 diabetes mellitus (DMT2). A total of 100 DMT2 patients participated in this prospective observational study. Plasma endocan levels were significantly elevated in DMT2 patients with HbA1c > 7% (1.38 ± 0.33 vs 0.68 ± 0.23 ng/mL; P < 0.0001), compared to patients with HbA1c ≤ 7%. Patients with plasma endocan concentrations >1.10 ng/mL (median value of 1.10 ng/mL) demonstrated significantly higher levels of metabolic parameters: body mass index (BMI), HbA1c (%), fasting glucose level, LDL cholesterol, total cholesterol, triglycerides, along with significantly lower HDL cholesterol levels. Furthermore, patients with plasma endocan levels >1.10 ng/mL were found to have an increased risk for the following complications: retinopathy (relative risk [RR]: 2.7500; 95% confidence interval [CI]: 1.2150–6.2244; P = 0.0152, nephropathy (RR: 2.0952; 95% CI: 1.2294–3.5710; P = 0.0065), neuropathy (RR: 1.9945; 95% CI: 1.2025–3.3081; P = 0.0075), angina pectoris (RR: 2.4881; 95% CI: 1.0865–5.6979; P = 0.0311, hypertension (RR: 1.1372; 95% CI: 1.0060–1.2856; P = 0.0398), cardiomyopathy (RR: 2.6190; 95% CI: 1.1507–5.9612; P = 0.0218), myocardial infarction (RR: 9.4286; 95% CI: 1.2742–69.7697; P = 0.0280) and stroke (RR: 4.4638; 95% CI: 1.3765–14.4758; P = 0.0127). Correlation analysis revealed that plasma endocan levels were positively correlated with HbA1c (%) (r = 0.856, P < 0.0001), fasting glucose level (r = 0.631, P < 0.0001), LDL (r = 0.347, P = 0.0004), cholesterol (r = 0.282, P = 0.0045), and triglycerides (r = 0.366, P = 0.0002). Conversely, plasma endocan levels were negatively correlated with HDL cholesterol (r = −0.429, P < 0.0001). In conclusion, higher plasma endocan levels were strongly associated with poor metabolic control in DMT2 patients and exhibited significant predictive value for both microvascular and macrovascular complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteoglycansDiabetes Mellitus, Type 2Neoplasm ProteinsHumansFemaleMaleMiddle AgedAgedProspective StudiesBiomarkersGlycated HemoglobinBlood Glucose

Substanzen

ESM1 protein, humanProteoglycansNeoplasm ProteinsBiomarkersGlycated HemoglobinBlood Glucose

Autor:innen und Institutionen

  • Department of Gynecology and Obstetrics, University Clinical Center Ljubljana, Ljubljana, Slovenia; Health Center of Sarajevo Canton, Sarajevo, Bosnia and Herzegovina; School of Medicine, University of Tuzla, Tuzla, Bos…
  • Department of Pharmacology, School of Medicine, University of Tuzla, Tuzla, Bosnia and Herzegovina.
  • Department of Family Medicine, Health Center of Tuzla, Tuzla, Bosnia and Herzegovina.
  • Department of Pharmacology, School of Medicine, University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
  • School of Medicine, University of Tuzla, Tuzla, Bosnia and Herzegovina.
  • Internal Medicine Clinic, University Clinical Center Tuzla, Tuzla, Bosnia and Herzegovina.

Zitieren

APA

Ljuca, K., Aščerić, M., Batić-Mujanović, O., Loga-Zec, S., Ljuca, N., Bećirović, E., Bejić, S., Jovanović, P., & Bećirović, M. (2024). Association of plasma endocan levels with metabolic parameters and predictive value of endocan for the development of complications in patients with type 2 diabetes mellitus: An observational study. Biomolecules and Biomedicine. https://doi.org/10.17305/bb.2024.11512

Vancouver

Ljuca K, Aščerić M, Batić-Mujanović O, Loga-Zec S, Ljuca N, Bećirović E, et al. Association of plasma endocan levels with metabolic parameters and predictive value of endocan for the development of complications in patients with type 2 diabetes mellitus: An observational study. Biomolecules and Biomedicine. 2024. doi:10.17305/bb.2024.11512

BibTeX
@article{Ljuca2024,
  author = {Ljuca, Kenana and Aščerić, Mensura and Batić-Mujanović, Olivera and Loga-Zec, Svjetlana and Ljuca, Nadina and Bećirović, Emir and Bejić, Samir and Jovanović, Predrag and Bećirović, Minela},
  title = {Association of plasma endocan levels with metabolic parameters and predictive value of endocan for the development of complications in patients with type 2 diabetes mellitus: An observational study},
  journal = {Biomolecules and Biomedicine},
  year = {2024},
  doi = {10.17305/bb.2024.11512}
}
Kostenlos starten →